Matthew Robson

Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer

Toshihiko Doi, Kei Muro, Narikazu Boku et al. · Journal of Clinical Oncology · 2010 · 212 citations

Medicine, Oncology, Pharmacology +16

Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma

Dorothy A. White, Philippe Camus, Masahiro Endo et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 211 citations

Medicine, Oncology, Pharmacotherapy +14

Phase I dose‐escalation study of buparlisib (<scp>BKM</scp>120), an oral pan‐class I <scp>PI</scp>3K inhibitor, in Japanese patients with advanced solid tumors

Megumi Inada‐Inoue, Ayako Mitsuma, Takayuki Yoshino et al. · Cancer Science · 2014 · 90 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors

Makoto Nishio, Haruyasu Murakami, Atsushi Horiike et al. · Journal of Thoracic Oncology · 2015 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.

Jean L. Grem, Emmet Jordan, Matthew Robson et al. · Journal of Clinical Oncology · 1993 · 68 citations

Medicine, Oncology, Pharmacology +15